Immunosuppression Does Not Reduce Antitumor Efficacy
- PMID: 30072006
- DOI: 10.1016/j.jacc.2018.04.087
Immunosuppression Does Not Reduce Antitumor Efficacy
Comment in
-
Reply: Immunosuppression Does Not Reduce Antitumor Efficacy.J Am Coll Cardiol. 2018 Aug 7;72(6):702. doi: 10.1016/j.jacc.2018.06.005. J Am Coll Cardiol. 2018. PMID: 30072007 Free PMC article. No abstract available.
Comment on
-
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19. J Am Coll Cardiol. 2018. PMID: 29567210 Free PMC article.
Similar articles
-
Reply: Immunosuppression Does Not Reduce Antitumor Efficacy.J Am Coll Cardiol. 2018 Aug 7;72(6):702. doi: 10.1016/j.jacc.2018.06.005. J Am Coll Cardiol. 2018. PMID: 30072007 Free PMC article. No abstract available.
-
[Myocarditis].Rev Med Interne. 2017 Aug;38(8):531-538. doi: 10.1016/j.revmed.2016.12.022. Epub 2017 Feb 2. Rev Med Interne. 2017. PMID: 28161113 Review. French.
-
Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.Herz. 2004 Sep;29(6):624-36. doi: 10.1007/s00059-004-2628-7. Herz. 2004. PMID: 15912438 Review.
-
Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.Circ Heart Fail. 2013 Jan;6(1):15-22. doi: 10.1161/CIRCHEARTFAILURE.112.969261. Epub 2012 Nov 13. Circ Heart Fail. 2013. PMID: 23149495
-
Immunosuppression and beta-blockade in heart failure.Cardiol Clin. 1989 Feb;7(1):171-81. Cardiol Clin. 1989. PMID: 2565162 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources